Literature DB >> 18164151

Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata.

F Seyfarth1, S Schliemann, P Elsner, U-C Hipler.   

Abstract

OBJECTIVES: Generally, chitosan is a water-insoluble polyaminosaccharide with antimicrobial activity. The antifungal activity of water-soluble low- and high-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-d-glucosamine against Candida albicans, Candida krusei and Candida glabrata was investigated.
METHODS: Solutions of the tested substances in different concentrations (1, 0.5, 0.25, 0.1, 0.05, 0.025, 0.01, 0.005, and 0.0025%) were prepared and the influence on C. albicans DSM 11225, C. krusei ATCC 6258 and C. glabrata DSM 11226 was investigated. Yeasts (3 x 10(5) cells/mL) were incubated with Sabouraud liquid medium at 30 degrees C. Measurements were done with a microplate nephelometer (NEPHELOstar Galaxy, BMG LABTECH Ltd.) for 24 h. High values of light scattering correlate with strong cultural growth. Results were shown as growth curves and histograms displaying 24 h end points. These were compared with control by Mann-Whitney test. Furthermore, MIC(50%), MIC(80%) and Spearman correlation coefficients were calculated.
RESULTS: C. albicans and C. krusei were the most sensitive species. C. glabrata was also inhibited, whereas 1% of tested substances could not prevent its growth completely. However, only both chitosan hydrochlorides showed a definite antifungal effect with high correlation between inhibition and test concentration. Carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine showed only a weak or no antifungal activity, respectively.
CONCLUSIONS: Antifungal activity decreases with declining molecular mass (chitosan oligosaccharide and N-acetyl-D-glucosamine) and increasing masking of the protonated amino groups with functional groups (carboxymethyl chitosan).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164151     DOI: 10.1016/j.ijpharm.2007.11.029

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  35 in total

Review 1.  Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects.

Authors:  Tianhong Dai; Masamitsu Tanaka; Ying-Ying Huang; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2011-07       Impact factor: 5.091

2.  Enteric Viral Surrogate Reduction by Chitosan.

Authors:  Robert Davis; Svetlana Zivanovic; P Michael Davidson; Doris H D'Souza
Journal:  Food Environ Virol       Date:  2015-07-11       Impact factor: 2.778

Review 3.  Biopolymers: Applications in wound healing and skin tissue engineering.

Authors:  T G Sahana; P D Rekha
Journal:  Mol Biol Rep       Date:  2018-08-09       Impact factor: 2.316

4.  In vitro protoscolicidal effects of fungal chitosan isolated from Penicillium waksmanii and Penicillium citrinum.

Authors:  Mahdi Fakhar; Aroona Chabra; Bahman Rahimi-Esboei; Fatemeh Rezaei
Journal:  J Parasit Dis       Date:  2013-05-15

5.  In vitro assessment of the antimicrobial activity of wound dressings: influence of the test method selected and impact of the pH.

Authors:  Cornelia Wiegand; Martin Abel; Peter Ruth; Peter Elsner; Uta-Christina Hipler
Journal:  J Mater Sci Mater Med       Date:  2015-01-13       Impact factor: 3.896

6.  Design, characterization, and in vitro evaluation of antifungal polymeric films.

Authors:  Daniel A Real; María V Martinez; Agustín Frattini; Marina Soazo; Alicia G Luque; Marisa S Biasoli; Claudio J Salomon; Alejandro C Olivieri; Darío Leonardi
Journal:  AAPS PharmSciTech       Date:  2012-12-08       Impact factor: 3.246

Review 7.  Production of chitooligosaccharides and their potential applications in medicine.

Authors:  Berit B Aam; Ellinor B Heggset; Anne Line Norberg; Morten Sørlie; Kjell M Vårum; Vincent G H Eijsink
Journal:  Mar Drugs       Date:  2010-04-27       Impact factor: 5.118

8.  Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.

Authors:  Namrata Raman; Myung-Ryul Lee; Angélica de L Rodríguez López; Sean P Palecek; David M Lynn
Journal:  Acta Biomater       Date:  2016-07-12       Impact factor: 8.947

9.  Antifungal activity of chitosan nanoparticles and correlation with their physical properties.

Authors:  Ling Yien Ing; Noraziah Mohamad Zin; Atif Sarwar; Haliza Katas
Journal:  Int J Biomater       Date:  2012-07-08

10.  Low-molecular-weight chitosan scavenges methylglyoxal and N (ε)-(carboxyethyl)lysine, the major factors contributing to the pathogenesis of nephropathy.

Authors:  Chu-Kuang Chou; Shih-Ming Chen; Yi-Chieh Li; Tzu-Chuan Huang; Jen-Ai Lee
Journal:  Springerplus       Date:  2015-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.